Compare MCHB & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCHB | HCM |
|---|---|---|
| Founded | 1905 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.7B |
| IPO Year | N/A | N/A |
| Metric | MCHB | HCM |
|---|---|---|
| Price | $14.29 | $14.62 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $14.50 | $13.75 |
| AVG Volume (30 Days) | ★ 342.4K | 22.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.80% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $36.61 | N/A |
| Revenue Next Year | $5.40 | $16.12 |
| P/E Ratio | $12.70 | ★ $5.49 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.82 | $11.51 |
| 52 Week High | $16.02 | $19.50 |
| Indicator | MCHB | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 39.36 | 44.30 |
| Support Level | $14.01 | $14.15 |
| Resistance Level | $15.67 | $14.63 |
| Average True Range (ATR) | 0.54 | 0.43 |
| MACD | -0.12 | -0.05 |
| Stochastic Oscillator | 13.27 | 27.77 |
Mechanics Bancorp is an independent, full-service community bank. It provides personal banking, business banking, trust and estate, brokerage and wealth management services. Mechanics' retail banking products include personal checking, savings and loan products (including credit card, home equity, home mortgage and secured/unsecured loans), online banking and wealth management services (including trust and estate, investment management and financial planning services). Mechanics' banking products and services for businesses include business checking and savings accounts, business debit cards, online banking, cash management services, wealth management services, business credit cards, commercial real estate loans, equipment leasing and loans guaranteed by the Small Business Administration.
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.